NasdaqCM - Nasdaq Real Time Price USD

Forian Inc. (FORA)

Compare
2.0599 -0.0001 (-0.00%)
As of 1:42 PM EDT. Market Open.
Loading Chart for FORA
DELL
  • Previous Close 2.0600
  • Open 2.1000
  • Bid 1.4900 x 200
  • Ask 2.6300 x 200
  • Day's Range 2.0400 - 2.1000
  • 52 Week Range 2.0000 - 4.1500
  • Volume 5,527
  • Avg. Volume 10,468
  • Market Cap (intraday) 64.085M
  • Beta (5Y Monthly) 1.09
  • PE Ratio (TTM) 68.66
  • EPS (TTM) 0.0300
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.00

Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.

forian.com

36

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FORA

View More

Performance Overview: FORA

Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FORA
29.58%
S&P 500
20.19%

1-Year Return

FORA
18.58%
S&P 500
36.70%

3-Year Return

FORA
79.69%
S&P 500
24.48%

5-Year Return

FORA
85.89%
S&P 500
50.09%

Compare To: FORA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FORA

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    63.78M

  • Enterprise Value

    39.96M

  • Trailing P/E

    68.33

  • Forward P/E

    25.64

  • PEG Ratio (5yr expected)

    0.85

  • Price/Sales (ttm)

    3.18

  • Price/Book (mrq)

    2.49

  • Enterprise Value/Revenue

    1.96

  • Enterprise Value/EBITDA

    17.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.65%

  • Return on Assets (ttm)

    -6.32%

  • Return on Equity (ttm)

    5.63%

  • Revenue (ttm)

    20.37M

  • Net Income Avi to Common (ttm)

    1.31M

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    48.01M

  • Total Debt/Equity (mrq)

    94.49%

  • Levered Free Cash Flow (ttm)

    6.89M

Research Analysis: FORA

View More

Company Insights: FORA

Research Reports: FORA

View More

People Also Watch